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Abstract: Sponges can provide potential drugs against many major world-wide occurring 
diseases. Despite the high potential of sponge derived drugs no sustainable production 
method has been developed. Thus far it is not fully understood why, when, where and how 
these metabolites are produced in sponges. For the near future sea-based sponge culture 
seems to be the best production method. However, for controlled production in a defined 
system it is better to develop in vitro production methods, like in vitro sponge culture or 
even better sponge cell culture, culture methods for symbionts or the transfer of production 
routes into another host. We still have insufficient information about the background of 
metabolite production in sponges. Before production methods are developed we should 
first focus on factors that can induce metabolite production. This could be done in the 
natural habitat by studying the relation between stress factors (such as predation) and the 
production of bioactive metabolites. The location of production within the sponge should 
be identified in order to choose between sponge cell culture and symbiont culture. 
Alternatively the biosynthetic pathways could be introduced into hosts that can be cultured. 
For this the biosynthetic pathway of metabolite production should be unraveled, as well as 
the genes involved. This review discusses the current state of sponge metabolite production 
and the steps that need to be taken to develop commercial production techniques. The 
different possible production techniques are also discussed. 
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1. Introduction  
 
Marine sponges are a ‘gold mine’ with respect to the diversity of their secondary metabolites 
discovered during the past fifty years. Sponges can provide potential drugs against many major  
world-wide occurring diseases. Of the 18,000 marine natural products described, over 30% are from 
sponges and of the antitumor natural product patent registrations in recent years over 75% are from  
sponges [1,2]. An overview of marine natural products and their status in clinical trials can be found 
at: www.marinebiotech.org/pipeline.html. Many of these products originate from sponges. 
Sponges (phylum Porifera) appear to be very stable, long-lived animals, with growth rates that vary 
enormously between different groups. They are multi-cellular filter-feeding invertebrates living 
attached to a substratum in mostly marine, but also freshwater habitats. Sponges do not possess true 
tissue, but have different cell types with different functions, which together carry out normal body 
functions. To provide the sponges with food and oxygen and to excrete waste products a large amount 
of seawater is filtered. Many sponges have a symbiosis with micro-organisms. Symbionts include 
archaea, bacteria, fungi, cyanobacteria, and microalgae. Photosynthetic symbionts provide the sponge 
with photosynthetic nutrients, which they do not obtain by their own filter-feeding activities. 
For the development of a sustainable production method of sponge bioactive metabolites, more 
knowledge is necessary about the biology and the needs of the sponge in nature for both growth and 
metabolite production. There has been a lot of attention on the discovery of new bioactive metabolites. 
To develop these bioactive metabolites into medicines they need to be tested in clinical trials, for 
which substantial amounts of compounds are needed. The concentration of bioactive compounds in 
sponge tissue can be very low. For example, Lissodendorix sp. contains concentrations of about  
400 μg/kg of halichondrin B. This means that there is a need for a sustainable production method. To 
develop a sustainable production technique it must be known whether the sponge or its symbionts or 
both are responsible for the production of the bioactive compound and in the case the sponge is the 
producer, which cells are responsible for the production. Because of the low concentrations inside the 
sponge the amount of sponge biomass needed will be very high [3,4]. To be able to increase the 
production per sponge, more knowledge is needed on the biosynthetic pathways and their regulation, 
which includes factors that induce production of the metabolites [5].  
There are several possible strategies to produce sponge bioactive compounds. Wild harvest is 
ecologically undesirable, due to the large amounts of sponge biomass necessary for commercial 
applications [6]. We believe that potential strategies to produce bioactive compounds from sponges 
include sponge or sponge cell cultures and genetic modification approaches in which large gene 
fragments responsible for production of the bioactive compounds are identified and transferred into a 
suitable host. So far, none of the approaches resulted in applicable technologies for production of 
sponge bioactive compounds despite significant progress. In this paper we will discuss the two major 
bottlenecks for sponge metabolite production, namely: Understanding metabolite production in the 
sponge, and choosing and improving culture systems. We propose a strategy how to develop a sponge 
metabolite production process in the following order: 
1. To understand metabolite production following steps are needed: 
- Identification of induction factors of metabolite production. 
- Identifying biosynthetic pathways of secondary metabolites. 
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- Identification of the location of bioactive compound production. 
2. Choosing and improving one of the following culture systems: 
- Whole sponge culture. 
- Sponge cell culture. 
- Symbiont culture. 
- Genetic modification. 
 
2. Understanding Metabolite Production in the Sponge 
 
2.1. Induction of Sponge Metabolite Production 
 
It is generally assumed that sponges produce secondary metabolites because they have to compete 
for space with other organisms, they have to prevent fouling by other organisms and they have to keep 
predators away [7] (Figure 1). The highest frequency of toxic or deterrent metabolites is found in high 
competing environments. Bioactive compounds are for example often discovered in coral reefs with an 
enormous biodiversity. Furthermore, sponges found in exposed areas that are vulnerable to fish 
predators are usually more toxic than those growing unexposed [8]. For example, chemical deterrence 
of fish predators was found significantly higher for extracts obtained from the tropical sponge 
community as compared to the temperate community where less predation occurs [9]. Predation 
pressure thus increases investment into chemical defense and sponges have evolved in higher or lower 
bioactive compound producing specimen due to possible predation. 
 
Figure 1. Sponges competing: (A) Dysidea avara (right) competing for space with a soft 
leather coral, (B) Aplysina aerophoba fouled with hydrozoa, (C) Haliclona oculata 
predated by a nudibranch. 
 
 
Sponge bioactive metabolite concentrations were found to be variable corresponding to several 
environmental factors. The season and variation in temperature, location and illumination all have 
significant effect on bioactive metabolite concentration. A positive correlation between temperature 
and metabolite concentration was found for salicylihalmide A in Haliclona sp. [10], and mycalamide 
A in Mycale hentscheli [11]. Crambe crambe from the Mediterranean appears to be less toxic in well 
illuminated habitats compared to shaded habitats [12]. Also for other invertebrates variations were 
found. For example, the bioactive compound ascididemin from the ascidian Cystodytes sp. shows a 
seasonal trend and a positive correlation with temperature [13]. 
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The sponge Dysidea avara (Figure 1) competes for space with a leather coral. It is expected that 
under such circumstances the sponge produces more bioactive compounds than in absence of space 
competing organisms. There are only a limited number of such cases that have been studied, but they 
all support this hypothesis [14,15]. Several studies have shown that sponges and sponge extracts are 
deterrent towards predators like fishes [16–19]. It is often suggested that sponges are induced to 
produce more bioactive compounds when predated [7]. In terrestrial plants this mechanism has been 
well studied. The most common inducer of secondary metabolites in plants is herbivory by insects 
[20]. Also, in gorgonians it has been shown that the natural product content could be increased 
significantly in the presence of predator snails [21]. 
There are several examples that support the theory of possible induction of metabolite production 
due to stress factors. Transplantation, infection and different diets showed to induce metabolite 
production. Individuals transplanted from depth to near surface substantially increased the production 
of the natural product diterpenes in harvested sponge tissue of Rhopaloeides odorabile [22]. Aplysina 
aerophoba increased aplysinimine production in regions of the sponge close to infected sponge tissue, 
suggesting a defense response to the denser microbial community in the diseased part of the sponge 
[23]. Stevensine (an alkaloid metabolite) levels were significantly elevated in the experimental group 
of sponge explants cultured in vitro that were given a mixed diet of food particles at three times the 
natural environment particle concentration compared to sponges fed normal particle  
concentration [24].  
Another possibility to induce metabolite production is called activated chemical defense, which is 
induced by wounding. The probable ecological relevance of this mechanism is protection of the 
damaged sponge tissue from invasion of bacterial pathogens [25]. Wound activation of protoxins 
results in a pronounced increase of fish deterrent activity of A. aerophoba [26]. In Aplysina it was 
shown that wound-activated chemical defense occurs most likely by enzymatic conversion [27]. Due 
to wounding, brominated isoxazoline alkaloids were converted into the monocyclic nitrogenous 
compounds aeroplysinin-1 and dienone by enzymatic cleavage [25]. Wound regeneration was found to 
be slower in sponges with chemical defense than in sponges without chemical defense [28]. The 
difference in regeneration rate is suggested to be the result of two different strategies where the sponge 
either invests in a high regeneration rate or in producing compounds for chemical defense. 
Despite the differences found in bioactive metabolite concentrations at different environmental 
circumstances, for most sponges it is still unknown which factors induce production of bioactive 
compounds. As sponges react to predation, wounding and stress in general, there are probably specific 
inducers that trigger these responses. No studies have been performed to find which specific 
compounds induce secondary metabolite production inside the sponge. Finding such inducers would 
be of great value, since it would allow the induction of chemical defense and the associated metabolite 
production without the negative effects of, for example, wounding. If, for example, studies in situ 
reveal that production is induced due to the presence of predators. Extracts of the predator can be 
analyzed and gradually purified and tested on the sponges with the goal to identify the bioactive 
compound inducing chemical defense.  
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2.2. Biosynthesis of Secondary Metabolites 
 
Inducible production of bioactive compounds can also be helpful in identifying the genes involved. 
Information on the genes involved in metabolite production can then be obtained by comparing the 
gene expression before and after inducing bioactive metabolite production. A sequenced genome or a 
priori knowledge of enzymes involved greatly facilitates this approach. 
The complex interaction between sponges and symbionts is one of the reasons that relatively little 
genome research is done on sponges. Technically, it is difficult to separate the DNA of the sponge 
from that of the other organisms. Recently, the first sponge genome project was launched by the 
University of Queensland, Australia. The only sponge of which the genome is sequenced and 
published is Amphimedon queenslandica (www.compagen.org). In order to make faster progress in 
drug development a method is necessary with which it is possible to screen complex genetic material. 
Metagenomics has developed to be valuable as a tool for studying complex communities [29].  
Sponges can be seen as complex communities due to the presence of many symbionts. 
Developments in metagenomics have provided new insights in sponge metabolite production [30,31]. 
It can be used to find if certain pathways are of bacterial or sponge origin. For example, polyketide 
synthase (PKS) enzymes are involved in the synthesis of many natural products [32] and were found to 
be of bacterial origin inside several sponges [31,33]. Identifying gene fragments involved in bioactive 
metabolite production becomes more difficult when more complex metazoan genomes are studied for 
isolation of specific biosynthetic genes [33]. A targeted approach should be used to begin this complex 
study. Many marine natural products are terpenes [34] and thus a good start to investigate gene 
expression in sponges would be to focus on the mevalonate pathway, which is a known common 
terpene biosynthesis pathway [5]. 
Another technique to get more insight in sponge metabolism is to study the metabolome, i.e., the 
complete set of metabolites. Techniques to study the metabolome have developed fast in the recent 
years [35]. The metabolome is the final product of gene expression in a cell and thus represents the 
interaction of all biochemical processes. Metabolome studies in sponges on bioactive compounds have 
not been done yet, but it is done in sponges for fatty acid (FA) metabolism. Biosynthesis of fatty acids 
has been studied in different sponges by labeling techniques [36,37]. 14C-label was used by Hahn et al. 
to elucidate the biosynthesis of two long chain ‘demospongic acids’ in the sponge Microciona 
prolifera. Synthesis of these fatty acids was found to be done by elongating exogenous short chain 
FAs. Carbon isotopic labeling can be used to study intermediates of different compounds, or labeled 
intermediates can be fed to study further conversion pathways [38]. Multigene expression analysis in 
combination with metabolic analysis can be used to study production of bioactive compounds under 
stress conditions. This enables monitoring of expression levels of genes involved in the biosynthetic 
route of the bioactive compound. 
 
2.3. Location of Secondary Metabolite Production in the Sponge 
 
To be able to choose a production system it is necessary to know where the metabolites are 
produced in the sponge. Very often it is not known whether the sponge or the sponge symbiont is 
responsible for the production of the bioactive compound. Even in cases this is known, it is not known 
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if the sponge-symbiont relation is important for the production of the bioactive compound. It is often 
suggested, but has never been demonstrated, that in case the bioactive compound is produced by the 
sponge cell, the precursor for that compound might have been produced by an associated 
microorganism. Even in cases the compound is present in the sponge cell it may have been produced 
by a symbiont and stored in the sponge cell. It is often suggested that sponge symbionts are so tightly 
coupled that the microbial genome size is reduced, making the symbiont for nutrition dependent of the 
sponge or even that the genomes of sponge and symbiont are integrated [39–41]. 
In different studies it was shown that sponge bioactive compounds are stored in specific parts of the 
sponge, such as the outer layer, which is most exposed to predators. The secondary metabolite 
desacetylscalaradial was found in higher concentrations in the tips than in the base of the branching 
sponge Cacospongia sp. [42]. In Rhopaloeides odorabile, diterpene concentrations were found highest 
in the surface tissue [22]. Similar results were found for Ectoplasia ferox as larger concentrations of 
triterpene glycosides were found in the top layer of the sponge tissue [43]. However, the same article 
presents the opposite for Erylus formosus, where higher concentrations of formoside were found in the 
inner part of the sponge. Thus several studies support that highest concentrations are produced in the 
most vulnerable parts of the sponge.  
 
Figure 2. Flow sorting using flow cytometry. Cells can be charged based on difference in 
fluorescence or size (http://missinglink.ucsf.edu/lm/molecularmethods/flow.htm). 
 
 
Several methods have been used to identify the location of the bioactive compound in the different 
cell types of the sponge and its symbionts. For this the different cell fractions from sponges are 
isolated by flow sorting [44] (Figure 2) and Ficoll or Percoll density gradient centrifugation [45,46]. 
These cell fractions can then be analyzed for bioactive metabolites and intermediates of the 
biosynthetic route. An example of a bioactive compound produced by the sponge is stevensine from 
Axinella corrugata. Stevensine was also produced in a primary sponge cell culture [47]. Unson and 
Faulkner [44] found that cyanobacteria are responsible for the production of chlorinated metabolites, 
however the sequiterpenoids were only found in the sponge cells. In the Haplosclerid sponge 
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Haliclona sp. the cytotoxic alkaloids were located in the sponge cells [45]. This is also the case for 
avarol from Dysidea avara, which is located in the choanocytes [46].  
In some cases, the symbionts and not the sponge cells are the likely source of the secondary 
metabolites of interest [48,49]. For example, the polybrominated biphenyl ether antibiotics isolated 
from the sponge Dysidea herbacea are produced by the endosymbiotic cyanobacterium Oscillatoria 
spongeliae [44]. Manzamine in the sponge Acanthostrongylophora is produced by the associated 
microorganism from Micromonospora sp [50]. Another example is the production of dysiherbaine in 
the endosymbiotic cyanobacterial cells of the genus Synechocystis in the sponge Lendenfeldia 
chondrodes [51]. Fungi associated with marine sponges are also known to produce many bioactive 
agents [52]. Work on isolation and cultivation of sponge symbionts and the nature of symbiotic 
relationships have been reviewed elsewhere [48,53].  
Cell types that can be isolated to study the location of metabolite production are bacteria, 
microalgae and different types of sponge cells in which presence of bioactive compounds is expected. 
Sponge cell types of interest in this respect are the archeaocytes, choanocytes and pinacocytes. It is 
mostly suggested that archeaocytes are responsible for the production of secondary metabolites. Since 
one of the reasons to make bioactive compounds is protection against predators, one would expect 
these compounds to be present in the pinacocytes, which form the outer layer of the sponge. However, 
so far it is not shown that pinacocytes contain bioactive compounds. When compounds are found in 
specific cells it can still be that intermediates or precursors may have been produced by associated 
microorganisms or other cells. The debate about this is mainly based on speculation and we have to 
conclude that at present it is unknown in which cell types the bioactive compounds and their 
intermediates are produced.  
 
3. Culture Systems 
 
3.1. Sponge Culture  
 
Sipkema et al. [4] concluded that whole sponge culture is the most promising option for large scale 
production of higher concentrated metabolites like avarol, which is produced up to 3 g per kg sponge 
wet weight [54] in Dysidea avara. Especially for faster growing sponges containing large amounts of 
metabolites whole sponge culture is potentially interesting. It was determined that sea-based culture is 
economically cheaper than land-based culture [4]. The major drawback of culturing sponges is that 
many sponges were found to be slow or variable growing organisms both in the sea [55–60] as well as 
in the laboratory [61–67]. Studies have demonstrated that production of metabolites in cultured 
sponges was sometimes lower [57], but on the other side also higher production rates were found 
[11,68] than in sponges harvested from the sea. Apart from the costs, sea-based culture is less desirable 
than land-based culture as the conditions cannot be controlled in the sea, and the sponges are 
vulnerable to diseases and parasites. Several attempts have been made to culture sponges on land. 
Most of the research focused on food requirements, which is thought to be the key to success [69]. 
Sponge cultures in the sea can be done using different structures for attaching sponges (Figure 3), and 
harvesting could be done partially thus leaving explants behind to re-grow. Sea-based cultivation is 
still the method where the largest growth rates have been obtained. Apparently, the artificial 
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environment we construct for the sponges still cannot replace the complexity of the sea. A good 
alternative for this is to culture sponges on land but still use natural seawater flowing through the 
aquaria containing the sponges. Despite several growth studies still very limited understanding is 
present about the exact needs of sponges to improve growth. Therefore, before sponge culture systems 
can be realized more understanding is necessary about food, attachment surfaces and other 
requirements that stimulate sponge growth.  
 
Figure 3. Different attachment forms for sea-based culture. Sponges on (A) threads, (B) in 
cages, (C) on tiles, attached using a plastic band, where sponges attach to the tile 
themselves within one month.  
 
 
3.2. Sponge Cell Culture  
 
In the cases that the sponge cells are responsible for the bioactive metabolite production [46,70,71], 
sponge cell culture would be an obvious method to use. In vitro culture of sponges as dissociated 
sponge cells or tissue would provide a clean and defined system for the production of sponge 
metabolites. However, attempts to develop continuously proliferating cell lines from sponges have 
failed so far. When achieving a continuously dividing sponge cell culture, cells can be grown in 
controlled bioreactors and controlling circumstances and stimulating production inside the cells will be 
much easier than in whole sponges. In addition, the use of these bioreactors makes scale up also easier 
(Figure 4). The difficulty with obtaining sponge cell lines is that cells do not continuously divide, 
because it is not known what sponge cells need in order to grow [47,72]. However, phytohemaglutin 
promoted cell division of sponge cells in culture [47]. Another problem encountered in these studies is 
getting the culture axenic, as sponges themselves are not axenic. Using undifferentiated cells may 
improve cell adjustment to the new environment. Thus far archeaocytes are the most promising cells in 
sponges to use for cell culture due to their pluripotency. However, using embryonic cells as starting 
material for cell culture may improve the chance in obtaining continuously dividing cells  
significantly [73].  
 
 
 
 
Mar. Drugs 2009, 7              
 
 
795
Figure 4. Development of sponge cell-lines. (A) Dysidea avara (B) cells isolated from 
Dysidea avara (C) bioreactor to culture animal cells. 
 
There are a number of observations that showed that besides stimulating cell proliferation, also 
prevention of cell death may be important for the development of continuous cell lines. These 
observations are slow growth rates of sponges [56,60], in combination with fast healing of wounded 
tissue [63], reorganization of sponge tissue [74], DNA replication and no net growth of primmorphs 
[75] and fast DNA replication and probably apoptosis in whole sponge specimens [73]. We 
hypothesize that sponges may grow fast and die fast at the same time. This could be the reason that 
sponges are successful animals during evolution. Cells will not show any malfunctioning due to ageing 
because of the high turn over of cells, and the organism as a whole responds to attacks simply by 
giving up that part and building new cells. If this is true then sponges are very dynamic organisms that 
show a very slow net growth as a result of fast cell division and at the same time a high rate of 
apoptosis. For the development of continuous growing cell lines the strong capability of sponge cells 
to divide should be used and apoptosis should be prevented. A final advantage of sponge cell culture is 
that when understanding metabolic pathways and inducing factors for metabolite production the 
medium and culture conditions can be easily adjusted to improve production rates.  
 
3.3. Symbiont Culture 
 
If symbiotic micro-organisms inside the sponge are responsible for the production of the bioactive 
metabolites then of course culturing these symbionts would be the best option. Thus far few 
publication have focused on culturing symbionts, and first successes have been obtained [76,77]. To 
culture sponge-associated symbiont remains very difficult because of the difficulty in isolating and 
pure cultivation. Some microorganisms will not grow in pure culture, but can form colonies in the 
presence of other microorganisms [78]. Isolation of sponge-associated bacteria was best when using 
oligotrophic media [77]. Addition of sponge extract seems to have a positive effect on cultivability 
[76]. Isolated morphotypes from different sponge species were mostly affiliated to the 
Alphaproteobacteria, although also members of the genus Bacillus were found regularly. One 
alphaproteobacterium was found to dominate the culture which had microbial activity. Although weak 
and unstable, the cells lost activity during culture [77]. Thus, symbiotic bacteria cultivation did work, 
but keeping bioactivity is difficult. However, Kennedy et al. [79] showed that 50% of the isolated 
bacteria from Haliclona simulans possessed antimicrobial activity. Bioactive metabolite producing 
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symbionts in culture are still very difficult to obtain. However, nowadays, more efforts are made 
towards development of sponge symbiont culture. 
 
3.4. Genetic Modification  
 
Metagenomics is the genetic analysis of a complex microbial mixture that can be used to analyze 
sponge microbial associations. Metagenomic approaches have also been used in which large gene 
fragments important for production of the bioactive compounds are identified, which could then be 
transferred to a suitable host [80]. This is a very promising technique, but a complex biosynthesis 
pathway means involvement of many genes, all of which need to be identified and all need to be 
transferred to the other host. Metabolic engineering is under development and the number of successes 
in introducing combinations of many genes is increasing lately [81–83].  
For plant natural products recent advancements were made in the production of terpenoids, 
phenylpropanoids and alkaloids by using different techniques including protein engineering, codon 
optimization and combinatorial biosynthesis [84]. Paclitaxel (Taxol) is a classical example of a plant 
natural product produced in Taxus brevifolia. Taxol is a complex terpenoid that can be used for the 
treatment of breast cancer. Recently, a step forward was made in the production of Taxol in the yeast 
Saccharomyces cerecisiae. Heterologous genes were introduced encoding biosynthetic enzymes for 
the beginning of the taxoid biosynthetic pathway, as well as a regulatory factor inhibiting competitive 
pathways [82]. Especially the combination of combinatorial biosynthesis and elements to inhibit 
competitive pathways made it possible to increase the production of the intermediate taxadiene in 
yeast 40-fold to 8.7 mg/L. 
The group of Keasling of the University of California, Berkeley has made major progress in 
expressing multiple genes in both yeast (Saccharomyces cerevisiae) and bacteria (Escherichia coli). 
For example, genes encoding for the anti-malarial drug artemisinin, a sesquiterpene, have been 
expressed in S. cerevisiae. A single plasmid was used to express a combination of three plant genes 
and 84% of the plasmids were stable in the cells producing the intermediate amorphadiene, whereas 
poor plasmid stability was found in cells synthesizing artemisinic acid [83]. E. coli has also been 
employed in the production of the intermediate amorphadiene [81]. A simple cloning system for 
expressing the whole pathway enabled identification of rate limiting enzymes, which then could be 
over expressed to increase production seven-fold [81]. Thus, development of expressing multiple 
genes in host organisms is in full speed and when biosynthetic pathways are identified in sponges this 
road should be open for sponge drug development as well. However, difficulties are still to be 
overcome to be able to produce the toxic end products in host organisms, as the bioactive compounds 
can have toxic effects to the host organism itself.  
 
4. Concluding Summary 
 
For the development of sponge derived drugs still major breakthroughs are necessary. The best 
method to produce the different compounds depends on various factors. First focus of sponge derived 
drug development should be on why, when, how, and where the compound is produced. When being 
able to answer all these questions the best production method can be chosen. Then, focus should be put 
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on development of the production method. Thus far the most promising method is whole sponge 
production in the sea. This is due to the fact that we do not understand the needs of the sponge for both 
growth and production. In the sea all elements are available to the sponge for survival, growth and 
metabolite production. For clean and defined systems it is better to develop cell culture methods, either 
sponge cell culture, symbiont culture or other host organisms. Before proper production methods for 
sponge metabolites are developed still a lot of research is necessary.  
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